5513 related articles for article (PubMed ID: 3654216)
1. [Therapeutic use of alpha interferon in metastasizing malignant melanoma, disseminated Kaposi sarcoma and severe Behçet disease].
Stadler R; Bratzke B; Orfanos CE
Hautarzt; 1987 Aug; 38(8):453-60. PubMed ID: 3654216
[TBL] [Abstract][Full Text] [Related]
2. [Disseminated mucocutaneous Kaposi sarcoma in AIDS. Clinical and therapeutic experiences in 13 patients].
Bratzke B; Stadler R; Eichhorn R; Ehlers G; Orfanos CE
Hautarzt; 1987 May; 38(5):286-94. PubMed ID: 3610636
[TBL] [Abstract][Full Text] [Related]
3. [Therapy of AIDS-induced Kaposi sarcoma and malignant melanoma with interferons].
Stadler R; Bratzke B; Mayer da Silva A; Orfanos CE
Onkologie; 1988 Aug; 11(4):166-76. PubMed ID: 3054668
[TBL] [Abstract][Full Text] [Related]
4. [Interferon alpha 2C in the treatment of 2 patients with AIDS-associated Kaposi sarcoma].
Steger G; Dittrich C; Eichler HG; Flener R; Moser K
Wien Klin Wochenschr; 1987 Feb; 99(4):120-3. PubMed ID: 3577187
[TBL] [Abstract][Full Text] [Related]
5. [Current status of interferon therapy].
Dittrich C
Wien Med Wochenschr; 1986 Apr; 136(7-8):163-72. PubMed ID: 2425497
[TBL] [Abstract][Full Text] [Related]
6. Exacerbation of epidemic Kaposi's sarcoma with a combination of interleukin-2 and beta-interferon: results of a phase 2 study.
Krigel RL; Padavic-Shaller KA; Rudolph AR; Poiesz BJ; Comis RL
J Biol Response Mod; 1989 Aug; 8(4):359-65. PubMed ID: 2666585
[TBL] [Abstract][Full Text] [Related]
7. [Behçet disease and exogenous interferon. A successful treatment study using recombinant alpha-A-IFN].
Stadler R; Bratzke B; Baumann I
Hautarzt; 1987 Feb; 38(2):97-100. PubMed ID: 3570783
[TBL] [Abstract][Full Text] [Related]
8. [Therapeutic response of interferon-beta in malignant melanoma].
Ishihara K
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1010-6. PubMed ID: 2421645
[TBL] [Abstract][Full Text] [Related]
9. Kaposi's sarcoma: a reevaluation.
Orfanos CE; Husak R; Wölfer U; Garbe C
Recent Results Cancer Res; 1995; 139():275-96. PubMed ID: 7541146
[TBL] [Abstract][Full Text] [Related]
10. Clinical phase II trial of recombinant DNA interferon (interferon alpha 2b) in patients with metastatic malignant melanoma.
Dorval T; Palangie T; Jouve M; Garcia-Giralt E; Israel L; Falcoff E; Schwab D; Pouillart P
Cancer; 1986 Jul; 58(2):215-8. PubMed ID: 3719515
[TBL] [Abstract][Full Text] [Related]
11. [Alpha 2 -interferon therapy in metastasizing malignant melanoma].
Landthaler M; Geyer C; Papendick U; Braun-Falco O
Dtsch Med Wochenschr; 1987 Jun; 112(23):919-21. PubMed ID: 3582200
[TBL] [Abstract][Full Text] [Related]
12. [Intralesional therapy of melanoma metastases with recombinant interferon-beta].
Fierlbeck G; d'Hoedt B; Stroebel W; Stutte H; Bogenschütz O; Rassner G
Hautarzt; 1992 Jan; 43(1):16-21. PubMed ID: 1612904
[TBL] [Abstract][Full Text] [Related]
13. Preliminary observations on the effect of recombinant leukocyte A interferon in homosexual men with Kaposi's sarcoma.
Krown SE; Real FX; Cunningham-Rundles S; Myskowski PL; Koziner B; Fein S; Mittelman A; Oettgen HF; Safai B
N Engl J Med; 1983 May; 308(18):1071-6. PubMed ID: 6835320
[No Abstract] [Full Text] [Related]
14. Unexpected toxicity from radiation therapy in two patients with Kaposi's sarcoma receiving interferon.
Real FX; Krown SE; Nisce LZ; Oettgen HF
J Biol Response Mod; 1985 Apr; 4(2):141-6. PubMed ID: 3998765
[TBL] [Abstract][Full Text] [Related]
15. Biotherapy with interferon in AIDS-related Kaposi's sarcoma.
Mitsuyasu RT; Miles SA
Oncol Nurs Forum; 1987; 14(6 Suppl):27-31. PubMed ID: 3320983
[No Abstract] [Full Text] [Related]
16. Intralesional human leukocyte interferon treatment in the non-AIDS related Kaposi's sarcoma.
Alecu M; Ghyka G; Hălălău F; Călugăru A; Coman G
Med Interne; 1990; 28(1):61-7. PubMed ID: 2284569
[TBL] [Abstract][Full Text] [Related]
17. [Interferon (IFN) therapy (recombinant IFN-alpha-2C or recombinant IFN-gamma) in metastasized hypernephroma].
Kuzmits R; Scheithauer W; Ludwig H; Flener R
Acta Med Austriaca; 1985; 12(5):129-34. PubMed ID: 3938590
[TBL] [Abstract][Full Text] [Related]
18. Phase II study of recombinant interferon-gamma in patients with disseminated malignant melanoma.
Creagan ET; Ahmann DL; Long HJ; Frytak S; Sherwin SA; Chang MN
Cancer Treat Rep; 1987 Sep; 71(9):843-4. PubMed ID: 3113730
[TBL] [Abstract][Full Text] [Related]
19. [Local application of interferon beta to skin lesions of malignant melanoma and malignant lymphoma--clinical and histopathological analysis].
Ito Y; Jimbow K; Miura S; Maeda K
Gan To Kagaku Ryoho; 1984 Jun; 11(6):1263-8. PubMed ID: 6732253
[TBL] [Abstract][Full Text] [Related]
20. [Combination of interferon-alpha with cytostatic drugs: a potentially successful therapeutic approach in metastatic melanoma].
Garbe C; Zouboulis CC; Krüger S; Waibel M; Kreuser ED; Stadler R; Orfanos CE
Hautarzt; 1992 Jan; 43(1):4-10. PubMed ID: 1369746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
